AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| 1 |
McDonald's
MCD
|
+$476M |
| 2 |
JPMorgan Chase
JPM
|
+$361M |
| 3 |
TJX Companies
TJX
|
+$360M |
| 4 |
Medtronic
MDT
|
+$310M |
| 5 |
Philip Morris
PM
|
+$251M |
Top Sells
| 1 |
Wells Fargo
WFC
|
+$491M |
| 2 |
Citigroup
C
|
+$369M |
| 3 |
Kroger
KR
|
+$338M |
| 4 |
Exxon Mobil
XOM
|
+$286M |
| 5 |
Goldman Sachs
GS
|
+$273M |
Sector Composition
| 1 | Financials | 15.76% |
| 2 | Technology | 15.37% |
| 3 | Healthcare | 13.85% |
| 4 | Consumer Discretionary | 10.87% |
| 5 | Industrials | 10.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NYRT
2651
DELISTED
New York REIT, Inc.
NYRT
| $408K | ﹤0.01% |
4,724
-1,130
| -19% | -$97.6K |
|
2652
Kinsale Capital Group
KNSL
$10B
| $407K | ﹤0.01% |
10,900
+4,100
| +60% | +$153K |
|
2653
Pacific Biosciences
PACB
$375M
| $407K | ﹤0.01% |
114,200
+35,700
| +45% | +$127K |
|
2654
Bank of Marin Bancorp
BMRC
$401M
| $406K | ﹤0.01% |
13,180
+3,000
| +29% | +$92.4K |
|
2655
TETRA Technologies
TTI
$640M
| $403K | ﹤0.01% |
144,573
+20,000
| +16% | +$55.8K |
|
|
SCMP
2656
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $403K | ﹤0.01% |
38,362
+9,000
| +31% | +$94.5K |
|
2657
Angi Inc
ANGI
$782M
| $402K | ﹤0.01% |
3,140
+728
| +30% | +$93.2K |
|
|
RSO
2658
DELISTED
Resource Capital Corp.
RSO
| $402K | ﹤0.01% |
39,560
+6,000
| +18% | +$61K |
|
2659
Citizens
CIA
$271M
| $401K | ﹤0.01% |
54,309
+12,800
| +31% | +$94.5K |
|
|
TRQ
2660
DELISTED
Turquoise Hill Resources Ltd
TRQ
| $400K | ﹤0.01% |
15,079
+8,168
| +118% | +$217K |
|
|
CSLT
2661
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $397K | ﹤0.01% |
95,750
+15,300
| +19% | +$63.4K |
|
|
WMC
2662
DELISTED
Western Asset Mortgage Capital Corporation
WMC
| $396K | ﹤0.01% |
3,840
+500
| +15% | +$51.6K |
|
2663
Rigel Pharmaceuticals
RIGL
$665M
| $395K | ﹤0.01% |
14,474
+2,860
| +25% | +$78.1K |
|
|
GARS
2664
DELISTED
Garrison Capital Inc.
GARS
| $395K | ﹤0.01% |
47,868
-62,486
| -57% | -$516K |
|
2665
Karyopharm Therapeutics
KPTI
$55.7M
| $393K | ﹤0.01% |
2,895
+700
| +32% | +$95K |
|
2666
QCR Holdings
QCRH
$1.32B
| $389K | ﹤0.01% |
+8,200
| New | +$389K |
|
2667
Atara Biotherapeutics
ATRA
$84.6M
| $388K | ﹤0.01% |
1,110
+368
| +50% | +$129K |
|
2668
Sunoco
SUN
$6.88B
| $388K | ﹤0.01% |
12,679
+710
| +6% | +$21.7K |
|
|
BLCM
2669
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $388K | ﹤0.01% |
3,320
+1,380
| +71% | +$161K |
|
2670
FlexShares International Quality Dividend Index Fund
IQDF
$812M
| $387K | ﹤0.01% |
+15,374
| New | +$387K |
|
2671
Ocular Therapeutix
OCUL
$2.22B
| $387K | ﹤0.01% |
41,700
+14,400
| +53% | +$134K |
|
2672
Ezcorp Inc
EZPW
$1.01B
| $386K | ﹤0.01% |
50,147
+2,600
| +5% | +$20K |
|
|
LGTY
2673
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
| $386K | ﹤0.01% |
37,492
+15,800
| +73% | +$163K |
|
2674
Option Care Health
OPCH
$4.75B
| $385K | ﹤0.01% |
35,475
+11,950
| +51% | +$130K |
|
|
SRGA
2675
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $384K | ﹤0.01% |
2,188
+220
| +11% | +$38.6K |
|